CureVac's new crown COVID-19 vaccine remains stable at standard refrigerator temperatures for 3 months

CureVac, a German biotechnology company, has announced that its new mRNA-based coronavirus COVID-19 vaccine CVnCoV is stable at room temperature for up to 24 hours and can remain stable for at least three months at a specific specification when stored at a standard refrigerator temperature of 5 degrees C (+41 degrees F).
testing of CVnCoV for the mechanism of action of the new crown vaccine for mRNA (Photo: NIH website) was carried out under the standard conditions of the International Coordinating Technical Requirements Council.
we are encouraged by the compatible stability of our candidate COVID-19 vaccine at standard refrigerator temperatures and room temperatures," said Florian von der Mülbe, chief production officer of the company.
this compatibility has the potential to spread storage and significantly promote mass vaccination during the current pandemic.
"CureVac added that research on vaccine stability is still ongoing with the aim of further evaluation to extend the shelf life of the product.
Photo Source: Pfizer and BioNTech announced the first phase of their mRNA candidate vaccine BNT162b2 on Monday, showing that the vaccine is more than 90 percent effective, but that the vaccine must be kept at ultra-low temperatures below -70 degrees Celsius, giving the vaccine a huge challenge in transportation.